Novo Nordisk
NVO
$62.08
Share price
-0.88%
Change (1 day)
-50.65%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Revenue for Novo Nordisk (NVO)
Revenue in 2024 (TTM): $41.89 Billion USD
According to Novo Nordisk's latest financial reports the company's current revenue (TTM 
) is $41.89 Billion USD. an increase over the revenue in the year 2023 that were of $33.81 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novo Nordisk from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $41.89 B | 23.89% |
| 2023 | $33.81 B | 34.98% |
| 2022 | $25.05 B | 13.81% |
| 2021 | $22.01 B | 11.61% |
| 2020 | $19.72 B | 7.92% |
| 2019 | $18.27 B | 3.71% |
| 2018 | $17.62 B | 2.27% |
| 2017 | $17.22 B | 3.93% |
| 2016 | $16.57 B | 3.64% |
| 2015 | $15.99 B | 3.1% |
| 2014 | $15.51 B | 4.18% |
| 2013 | $14.89 B | 9.28% |
| 2012 | $13.62 B | 11.19% |
| 2011 | $12.25 B | 14.14% |
| 2010 | $10.73 B | 11.21% |
| 2009 | $9.65 B | 6.03% |
| 2008 | $9.10 B | 15.87% |
| 2007 | $7.85 B | 18.71% |
| 2006 | $6.62 B | 20.12% |
| 2005 | $5.51 B | 11.42% |
| 2004 | $4.94 B | 16.64% |
| 2003 | $4.24 B | 18.54% |
| 2002 | $3.57 B | 0.74% |
| 2001 | $3.55 B | -17.97% |
| 2000 | $4.32 B | 40.49% |
| 1999 | $3.08 B | 12.69% |
| 1998 | $2.73 B | 11.43% |
| 1997 | $2.45 B | 13.11% |
| 1996 | $2.16 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $63.62 B | 51.88% | 🇺🇸 USA |
 | $45.04 B | 7.52% | 🇺🇸 USA |
 | $48.30 B | 15.30% | 🇺🇸 USA |
 | $47.96 B | 14.49% | 🇫🇷 France |